2 Results

Sort by: Published date Updated Date Title ID Descending Ascending

Boosting Immunogenicity of Vaccines Using Saponins and Agonists of the Intracellular STING Pathway Application Vaccine formulation of an activator of the stimulator of interferon genes (STING) pathway and saponin adjuvant for enhanced protection of aged population. Key Benefits Significantly improved protective immunity of vaccine in the aged. More efficient than the current methods of influenza vaccination of population 65 years of age or... Published: 2/13/2025       Contributor(s): Elena Vassilieva, Richard Compans

Novel Vaccine Antigen Presentation Platforms Application Combined antigen-adjuvant virus-like particle (VLP) vaccine platform for enhanced immune response. Key Benefits Chimeric VLPs (cVLPs) contain both antigen and adjuvant, thereby enhancing both cellular and humoral responses. cVLPs are safer than live replicating vectored vaccines because of their lack of infectivity. The cVLP manufacturing... Published: 2/13/2025       Contributor(s): Baozhong Wang, Fu Shi Quan, Martin Moore, Richard Compans, Alan Aderem, Ioanna Skountzou, Jadranka Bozja